↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Blog
  • PIV Data
    • Get Access
Home→Continuing Education

Continuing Education

Home › Forums › The ParagraphFour.com Library (Archives and Reference Sources) › Continuing Education

  • This forum has 11 topics, and was last updated 8 years, 4 months ago by gregoryglass.
Viewing 11 topics - 1 through 11 (of 11 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • Antibiotics Products

      Started by: gregoryglass

    • 1
    • 1
    • 12 years ago

      gregoryglass

    • Authorized Generics

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

    • Biosimilars

      Started by: gregoryglass

    • 1
    • 1
    • 15 years, 9 months ago

      gregoryglass

    • How a Paragraph IV Patent Case Works

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

    • Inter Partes Review

      Started by: gregoryglass

    • 1
    • 1
    • 8 years, 4 months ago

      gregoryglass

    • Listing Patents in the Orange Book

      Started by: gregoryglass

    • 1
    • 1
    • 15 years, 9 months ago

      gregoryglass

    • The Federal Trade Commission Study

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

    • The Grant of the 180 Day Exclusivity

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

    • The Paragraph IV Basics

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

    • The Paragraph IV Certification and Notice Process

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 6 months ago

      gregoryglass

    • Waiving the 180-day Exclusivity

      Started by: gregoryglass

    • 1
    • 1
    • 16 years, 7 months ago

      gregoryglass

  •  

Viewing 11 topics - 1 through 11 (of 11 total)
  • You must be logged in to create new topics.
Log In

Login

Log In

Latest updates

The Paragraph Four Report®
Paragraph IV Activity for February 2021

New Certifications as reported by FDA on February 8 and 23, 2021

1. Katerzia®(amlodipine) Oral Suspension 1 mg/mL on 12/29/2020
2. Balcoltra®(levonorgestrel and ethinyl estradiol) 0.1 mg/0.02 mg 7/14/2020
3. Osphena®(ospemifene) Tablets 60 mg on 12/29/2020
4. Car…Read more

Profile picture of parryashford 5 days, 20 hours ago

The Paragraph Four Report®
Paragraph IV Activity for January 2021

New Certifications as reported by FDA on January 26, 2021

1. Tirosint®(levothyroxine) Capsules 112 mcg on 12/18/2020
2. Ibrance®(palbociclib) Tablets 75 mg, 100mg, and 125mg on 11/24/2020
3. Xeljanz XR®(tofacitinib) Extended-release Tablets 22 mg on 12/28/2020
4. Ore…Read more

Profile picture of parryashford 1 month ago

Makena®(hydroxyprogesterone) Injection
Annual Sales
Company COVIS PHARMA (AMAG)
Date of First Filing September 28, 2020

Paragraph IV Applicant: Aurobindo
Case Name: COVIS PHARMA GMBH et al v. EUGIA PHARMA SPECIALTIES LTD et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00003
Date Filed: 1/4/21
Judge: Connelly
Product…Read more

Profile picture of parryashford 1 month, 3 weeks ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2021
↑